Loading company…
Neuralite develops technology to support the design and execution of neurological clinical trials.
Founded in 2021 and based in Tel Aviv, Neuralite provides technology for neurological clinical trials, aimed at streamlining trial processes and data collection. It serves research institutions and healthcare providers. In April 2022, the company raised USD 25.00 mn in Series A funding led by Koch Disruptive Technologies, with participation from Alumni Ventures Group, Breyer Capital, Samsung NEXT Ventures and VSC Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in